Company:  QUIDEL CORP /DE/ (QDEL)
Form Type:  8-K
Filing Date:  7/17/2017 
CIK:  0000353569 
Address:  12544 HIGH BLUFF DRIVE
SUITE 200
 
City, State, Zip:  SAN DIEGO, California 92130 
Telephone:  (858) 552-1100 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$37.55  
Change: 
-0.27 (-0.71%)  
Trade Time: 
Jul 25  
Market Cap: 
$1.25B
Trade QDEL now with

© 2017  
Description of Business
All references to "we," "our," and "us" in this Annual Report refer to Quidel Corporation and its subsidiaries. Overview We have a leadership position in the development, manufacturing and marketing of rapid diagnostic testing solutions. These diagnostic testing solutions are separated into our four product categories, including: immunoassays, molecular assays, virology and specialty products. We sell our products directly to end users and distributors, in each case, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, leading universities, retail clinics, pharmacies and wellness screening centers. We market our products in the United States through a network of national and regional distributors, and through a direct sales force. Internationally, we market primarily through distributor arrangements. We commenced our operations in 1979 and launched our first products, dipstick-based pregnancy tests, in 1983.
Register and access this filing in:     
  FORM 8-K
    SECTION 1 BUSINESS AND OPERATIONS
      Item 1.01 Entry into a Material Definitive Agreement.
    SECTION 9 FINANCIAL STATEMENTS AND EXHIBITS
      Item 9.01 Financial Statements and Exhibits.
    SIGNATURES
    EXHIBIT INDEX
  EXHIBIT 99
  EXHIBIT 10
  EXHIBIT 10
  EXHIBIT 10